内镜鼻窦手术对咽鼓管功能障碍症状的影响
该回顾性研究纳入302例因慢性鼻窦炎伴或不伴鼻息肉或复发性急性鼻窦炎接受内镜鼻窦手术的患者,术前及术后多个时间点完成ETDQ-7问卷。结果显示咽鼓管功能障碍症状在术后6个月内显著改善,术后6个月时不同疾病亚型的改善比例存在差异,术前疾病负担较高、后组筛窦切除及术后使用皮质类固醇喷剂与改善相关。
要点
- 内镜鼻窦手术可显著改善咽鼓管功能障碍症状
- 术后6个月CRSsNP改善率89%,CRSwNP为68%,RARS为78%
- 术前ETDQ-7和SNOT-22评分较高者更易改善
核心结论
- 咽鼓管功能障碍症状在内镜鼻窦手术后常得到改善。
- 改善相关因素包括术前疾病负担较高、后组筛窦切除及术后使用皮质类固醇喷剂。
研究设计与样本
- 回顾性病历审查,学术中心,纳入302例因慢性鼻窦炎伴或不伴鼻息肉或复发性急性鼻窦炎接受内镜鼻窦手术的患者。
- 术前及术后2周、6周、3个月、6个月完成ETDQ-7问卷,并分析人口学、合并症、SNOT-22、影像学评分、内镜评分、手术方式及用药。
主要发现
- ETD患病率在CRSsNP中为68%,CRSwNP中为48%,RARS中为88%。
- 有ETD的患者基线ETDQ-7均值为25.8±8.0,术后2周降至19.9±8.1(P<.001),6周17.8±9.3(P<.001),3个月16.8±8.5(P<.001),6个月16.4±7.9(P<.001)。
- 术后6个月ETD改善比例:CRSsNP为89%,CRSwNP为68%,RARS为78%。
- 多因素分析显示ETD改善与术前ETDQ-7评分较高(aOR 1.12,95%CI 1.04-1.22,P=.030)、术前SNOT-22评分较高(aOR 1.02,95%CI 1.02-1.08,P=.001)、术前SNOT-22耳部子评分较高(aOR 1.27,95%CI 1.02-1.65,P=.034)、后组筛窦切除(aOR 1.59,95%CI 1.22-4.92,P=.025)及术后皮质类固醇喷剂使用(aOR 1.57,95%CI 1.17-1.66,P=.008)相关。
临床怎么用
- 对于接受内镜鼻窦手术的慢性鼻窦炎患者,应关注咽鼓管功能障碍症状并在术前及术后评估ETDQ-7。
- 术前ETDQ-7或SNOT-22评分较高的患者可能从手术中获得更大的ETD症状改善。
- 后组筛窦切除及术后皮质类固醇喷剂使用可能与ETD改善相关,可在临床决策中参考。
局限性
- 回顾性研究,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed how eustachian tube dysfunction (ETD) changed with endoscopic sinus surgery (ESS) and identified factors associated with improvement. STUDY DESIGN: Retrospective chart review. SETTING: Academic center. SUBJECTS AND METHODS: Patients undergoing ESS for chronic rhinosinusitis with and without nasal polyposis (CRSwNP, CRSsNP) or recurrent acute rhinosinusitis (RARS) completed the Eustachian Tube Dysfunction Questionnaire 7 (ETDQ-7) preoperatively and postoperatively at 2 weeks, 6 weeks, 3 months, and 6 months. Included in analyses were demographics, comorbidities, Sinonasal Outcome Test 22 (SNOT-22), radiographic score, endoscopy score, procedure, and medication use. Regression analysis identified factors associated with improvement, defined as ΔETDQ-7 >3.5. RESULTS: In total, 302 patients were studied. ETD prevalence was 68% in CRSsNP, 48% in CRSwNP, and 88% in RARS. Patients with ETD had a mean baseline ETDQ-7 of 25.8 ± 8.0 and improved postoperatively at 2 weeks (19.9 ± 8.1, P < .001), 6 weeks (17.8 ± 9.3, P < .001), 3 months (16.8 ± 8.5, P < .001), and 6 months (16.4 ± 7.9, P < .001). At 6 months, ETD improved in 89% of patients with CRSsNP, 68% with CRSwNP, and 78% with RARS. On multivariate analysis, ETD improvement was associated with higher preoperative ETDQ-7 score (adjusted odds ratio [aOR], 1.12; 95% confidence interval [CI], 1.04-1.22; P = .030), higher preoperative SNOT-22 score (aOR, 1.02; 95% CI, 1.02-1.08; P = .001), higher preoperative SNOT-22 ear subscore (aOR, 1.27; 95% CI, 1.02-1.65; P = .034), posterior ethmoidectomy (aOR, 1.59; 95% CI, 1.22-4.92; P = .025), and postoperative corticosteroid spray use (aOR, 1.57; 95% CI, 1.17-1.66; P = .008). CONCLUSION: ETD symptoms often improve following ESS. Factors associated with improvement include higher preoperative disease burden, posterior ethmoidectomy, and postoperative corticosteroid spray. LEVEL OF EVIDENCE: 4.
引用
- Chang MT, Hosseini DK, Song SH, et al. The Effect of Endoscopic Sinus Surgery on Eustachian Tube Dysfunction Symptoms. Otolaryngol Head Neck Surg. 2020. PMID: 32343633. doi:10.1177/0194599820917396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。